Emergency vs elective presentation as a care-delivery phenotype in presumed early-stage lung cancer: A National Inpatient analysis.

D Daniel Thomas Jones (HCA Sunrise Health GME Consortium - MountainView Hospital, Las Vegas, NV) R Rishi Kumar Nanda (Touro University Nevada College of Osteopathic Medicine, Las Vegas, NV) R Ramaditya Srinivasmurthy (Mount Sinai Morningside, NY, New York, United States) J Jason Ta (HCA Healthcare/USF Morsani GME Consortium, HCA Florida Citrus Hospital, Florida, Florida, United States) R Riccesha Hattin (Kirk Kerkorian School of Medicine at UNLV, Las Vegas, Nevada, United States) A Abbas Hussain (Kirk Kerkorian School of Medicine at UNLV, Las Vegas, Nevada, United States) K Kyaw Zin Thein (3Comprehensive Cancer Centers of Nevada, Division of Hematology and Medical Oncology, Las Vegas, United States) D Deepti Behl (Mayo Clinic Rochester, Rochester, MN) K Konstantinos Leventakos (Mayo Clinic Rochester, Rochester, MN) M Mohamed Shanshal (Department of Medicine, Vanderbilt University Medical Center, Nashville)

Abstract

e23223 Background: Early-stage lung cancer is potentially curable with surgery, yet emergency or nonelective presentation represents a care-delivery phenotype reflecting failures in early diagnosis or access to care rather than tumor biology alone. The national impact of emergency presentation among surgically treated, presumed early-stage lung cancer patients is poorly defined. This study evaluates emergency versus elective presentation as a care-delivery phenotype and its association with perioperative morbidity, failure-to-rescue, and inpatient outcomes. Methods: A survey-weighted analysis of the National Inpatient Sample (2016–2023) was conducted. Adult lung cancer hospitalizations were identified using ICD-10-CM C34* in any diagnosis position. A presumed early-stage surgical cohort was defined by curative-intent lung resection without metastatic disease, malignant pleural effusion, or palliative care coding. The primary exposure was nonelective versus elective admission. Outcomes included in-hospital mortality; ICU-level care, defined by invasive mechanical ventilation, shock, or respiratory failure; major complications; failure-to-rescue; length of stay; and hospitalization cost and charges. Multivariable survey-weighted models adjusted for patient demographics, payer, neighborhood income, hospital characteristics, and year. Results: In the weighted cohort of 422,925 hospitalizations, nonelective admission occurred in 27.3%. After multivariable adjustment, nonelective admission was independently associated with higher odds of in-hospital mortality (adjusted odds ratio [aOR] 2.59, 95% CI 2.22–3.03), ICU-level care (aOR 4.53, 95% CI 4.32–4.76), and major complications (aOR 5.00, 95% CI 4.78–5.23), as well as longer length of stay (+2.42 days). Notably, failure-to-rescue among patients with major complications did not differ by admission type (aOR 0.90, 95% CI 0.77–1.05), indicating that excess mortality associated with nonelective presentation is driven by presentation severity and care pathway rather than differences in rescue quality. In unadjusted analyses, nonelective presentation was associated with higher mortality (2.21% vs 0.68%), greater ICU-level care use (33.8% vs 8.9%), more frequent major complications (45.0% vs 12.4%), and longer length of stay (7.84 vs 4.99 days) compared with elective admissions. Conclusions: In a procedure-defined, presumed early-stage lung cancer surgical cohort, nonelective admission identifies a common care-delivery failure phenotype associated with higher perioperative morbidity, ICU-level care, in-hospital mortality, and longer hospitalization. Emergency presentation represents a systems-level vulnerability in curative-intent lung cancer care and serves as a scalable and actionable marker for quality improvement and disparity-focused analyses.

Article Details

Volume / Issue Vol. 44, Issue 16_suppl
Published June 01, 2026
ISSN 0732-183X
Publisher Lippincott Williams & Wilkins

Journal Info

Journal of Clinical Oncology

Lippincott Williams & Wilkins

ISSN: 0732-183X Health Sciences

Authors (10)

D

Daniel Thomas Jones

HCA Sunrise Health GME Consortium - MountainView Hospital, Las Vegas, NV

R

Rishi Kumar Nanda

Touro University Nevada College of Osteopathic Medicine, Las Vegas, NV

R

Ramaditya Srinivasmurthy

Mount Sinai Morningside, NY, New York, United States

J

Jason Ta

HCA Healthcare/USF Morsani GME Consortium, HCA Florida Citrus Hospital, Florida, Florida, United States

R

Riccesha Hattin

Kirk Kerkorian School of Medicine at UNLV, Las Vegas, Nevada, United States

A

Abbas Hussain

Kirk Kerkorian School of Medicine at UNLV, Las Vegas, Nevada, United States

K

Kyaw Zin Thein

3Comprehensive Cancer Centers of Nevada, Division of Hematology and Medical Oncology, Las Vegas, United States

D

Deepti Behl

Mayo Clinic Rochester, Rochester, MN

K

Konstantinos Leventakos

Mayo Clinic Rochester, Rochester, MN

M

Mohamed Shanshal

Department of Medicine, Vanderbilt University Medical Center, Nashville